Clinical Trials Directory

Trials / Completed

CompletedNCT02528942

Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients

Early Phase Clinical Trial Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The proposed study is in the field of thoracic radiation oncology where radiation therapy is used to treat lung cancer. The primary objective of the early phase clinical trial will be to evaluate the safety of performing functional avoidance radiation therapy for lung cancer patients using 4D computed tomography (4DCT) ventilation imaging.

Detailed description

This study plans to learn more about radiation therapy. Radiation therapy is one of the main treatments used to treat lung cancer. One of the known side effects of this radiation therapy is scarring of the lungs and reduced lung function that can result in shortness of breath. At this time the radiation treatment plan does not take into account differences in lung function between one part of the lung and another. Studies have shown that lung function can vary substantially throughout the lungs. This study aims to plan the radiation therapy to be away from the highest functioning portions of lungs while still delivering the intended radiation dose to the tumor. This study will allow researchers to determine whether taking lung function information into account when designing radiation treatment plans can protect lung function after radiation therapy.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiation therapyRadiation therapy will be given to study patients.

Timeline

Start date
2016-04-22
Primary completion
2021-01-25
Completion
2021-01-25
First posted
2015-08-19
Last updated
2021-07-22
Results posted
2021-07-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02528942. Inclusion in this directory is not an endorsement.